Preventing Post–Organ Transplantation Cytomegalovirus Disease with Ganciclovir: A Meta‐Analysis Comparing Prophylactic and Preemptive Therapies
Open Access
- 1 October 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (7) , 869-880
- https://doi.org/10.1086/507337
Abstract
Background. Cytomegalovirus (CMV) causes significant morbidity and mortality in transplant recipients, but there is no consensus regarding the most aKeywords
This publication has 49 references indexed in Scilit:
- Canadian Society of Transplantation Consensus Workshop on Cytomegalovirus Management in Solid Organ Transplantation Final ReportAmerican Journal of Transplantation, 2005
- Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodiesTransplantation Proceedings, 2004
- Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti-lymphocyte globulin treatment for acute rejectionClinical Microbiology & Infection, 2004
- Preemptive Therapy Versus Universal Prophylaxis with Ganciclovir for Cytomegalovirus in Solid Organ Transplant RecipientsClinical Infectious Diseases, 2001
- Acyclovir prophylaxis of cytomegalovirus disease in kidney transplant recipientsTransplantation Proceedings, 1999
- Clinical practice guidelinesJournal of the American Society of Nephrology, 1998
- Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limitsTransplantation Proceedings, 1998
- GanciclovirDrugs, 1998
- Cytomegalovirus infection and disease after liver transplantationDigestive Diseases and Sciences, 1992
- Impact of Cytomegalovirus Infection on Organ Transplant RecipientsClinical Infectious Diseases, 1990